Nu-Med Plus, Inc. (NUMD)
USD 0.07
(-10.52%)
USD 0.07
(-10.52%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -125.52 Thousand USD | 4.3% |
| 2022 | -131.16 Thousand USD | 84.2% |
| 2021 | -830.06 Thousand USD | 58.98% |
| 2020 | -2.02 Million USD | -91.92% |
| 2019 | -1.05 Million USD | 11.32% |
| 2018 | -1.18 Million USD | -133.24% |
| 2017 | 3.57 Million USD | -62.94% |
| 2016 | 9.65 Million USD | 969.67% |
| 2015 | -1.1 Million USD | 6.94% |
| 2014 | -1.19 Million USD | -258.94% |
| 2013 | -332.29 Thousand USD | -26.47% |
| 2012 | -262.74 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -21.82 Thousand USD | 61.44% |
| 2024 Q2 | -17.28 Thousand USD | 20.8% |
| 2023 Q1 | -30.67 Thousand USD | -171.99% |
| 2023 FY | -125.52 Thousand USD | 4.3% |
| 2023 Q3 | -16.4 Thousand USD | 32.54% |
| 2023 Q2 | -24.32 Thousand USD | 20.7% |
| 2023 Q4 | -56.59 Thousand USD | -244.97% |
| 2022 Q1 | -53.65 Thousand USD | 52.24% |
| 2022 FY | -131.16 Thousand USD | 84.2% |
| 2022 Q4 | 42.6 Thousand USD | 173.4% |
| 2022 Q3 | -58.05 Thousand USD | 0.03% |
| 2022 Q2 | -58.07 Thousand USD | -8.23% |
| 2021 Q3 | -118.36 Thousand USD | 51.21% |
| 2021 FY | -830.06 Thousand USD | 58.98% |
| 2021 Q2 | -242.6 Thousand USD | 32.0% |
| 2021 Q1 | -356.74 Thousand USD | 27.69% |
| 2021 Q4 | -112.34 Thousand USD | 5.09% |
| 2020 Q4 | -493.37 Thousand USD | -8.71% |
| 2020 Q2 | -908.46 Thousand USD | -492.48% |
| 2020 Q3 | -453.82 Thousand USD | 50.05% |
| 2020 FY | -2.02 Million USD | -91.92% |
| 2020 Q1 | -153.33 Thousand USD | 26.94% |
| 2019 Q1 | -428.19 Thousand USD | -25.59% |
| 2019 Q3 | -150.57 Thousand USD | 39.33% |
| 2019 FY | -1.05 Million USD | 11.32% |
| 2019 Q4 | -209.87 Thousand USD | -39.38% |
| 2019 Q2 | -248.18 Thousand USD | 42.04% |
| 2018 Q1 | -147.48 Thousand USD | 3.36% |
| 2018 Q4 | -340.95 Thousand USD | 35.28% |
| 2018 Q3 | -526.84 Thousand USD | -203.56% |
| 2018 Q2 | -173.55 Thousand USD | -17.68% |
| 2018 FY | -1.18 Million USD | -133.24% |
| 2017 Q2 | -116.05 Thousand USD | -102.91% |
| 2017 FY | 3.57 Million USD | -62.94% |
| 2017 Q3 | -142.97 Thousand USD | -23.2% |
| 2017 Q4 | -152.61 Thousand USD | -6.74% |
| 2017 Q1 | 3.98 Million USD | -62.0% |
| 2016 Q1 | 42.42 Thousand USD | 114.8% |
| 2016 FY | 9.65 Million USD | 969.67% |
| 2016 Q4 | 10.49 Million USD | 1564.19% |
| 2016 Q3 | -716.8 Thousand USD | -325.65% |
| 2016 Q2 | -168.4 Thousand USD | -496.9% |
| 2015 FY | -1.1 Million USD | 6.94% |
| 2015 Q4 | -286.66 Thousand USD | 6.74% |
| 2015 Q3 | -307.37 Thousand USD | 21.84% |
| 2015 Q2 | -393.25 Thousand USD | -220.78% |
| 2015 Q1 | -122.59 Thousand USD | 77.04% |
| 2014 Q2 | -202.26 Thousand USD | 5.32% |
| 2014 FY | -1.19 Million USD | -258.94% |
| 2014 Q1 | -213.62 Thousand USD | -201.45% |
| 2014 Q4 | -533.89 Thousand USD | -119.76% |
| 2014 Q3 | -242.94 Thousand USD | -20.11% |
| 2013 Q3 | -142.09 Thousand USD | -287.44% |
| 2013 Q4 | -70.86 Thousand USD | 50.13% |
| 2013 FY | -332.29 Thousand USD | -26.47% |
| 2013 Q1 | -82.65 Thousand USD | 4.17% |
| 2013 Q2 | -36.67 Thousand USD | 55.63% |
| 2012 Q1 | -19.53 Thousand USD | 0.0% |
| 2012 Q2 | -46.24 Thousand USD | -136.72% |
| 2012 Q4 | -86.25 Thousand USD | 22.1% |
| 2012 Q3 | -110.71 Thousand USD | -139.43% |
| 2012 FY | -262.74 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -722.81 Thousand USD | 82.634% |
| IR-Med Inc. | -4.9 Million USD | 97.443% |
| Polarean Imaging plc | -11.88 Million USD | 98.944% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | 131.792% |
| Avitar, Inc. | -2.25 Million USD | 94.445% |
| AVITA Medical, Inc. | -39.16 Million USD | 99.68% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 89.225% |
| Össur hf. | 58.38 Million USD | 100.215% |
| Zecotek Photonics Inc. | -3.51 Million USD | 96.433% |
| QHSLab, Inc. | -468.36 Thousand USD | 73.199% |
| Wellstar International, Inc. | -3.1 Million USD | 95.962% |
| Össur hf. | 58.38 Million USD | 100.215% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | 105.337% |
| Escalon Medical Corp. | -125.26 Thousand USD | -0.212% |
| Aurora Spine Corporation | -1.68 Million USD | 92.531% |
| BrainsWay Ltd. | -4.19 Million USD | 97.009% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -11.49 Million USD | 98.908% |
| Hamilton Thorne Ltd. | -607.02 Thousand USD | 79.321% |
| Vivos Inc. | -2.89 Million USD | 95.664% |
| MicroPort Scientific Corporation | -477.62 Million USD | 99.974% |
| Kelyniam Global, Inc. | -218.47 Thousand USD | 42.543% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 92.939% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | 69.972% |
| Nanomix Corporation | -12.33 Million USD | 98.982% |
| Theraclion SA | -3.67 Million USD | 96.584% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | 83.329% |
| Positron Corporation | -1.63 Million USD | 92.34% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.64 Million USD | 95.247% |
| Lombard Medical, Inc. | -31.03 Million USD | 99.596% |
| ALR Technologies Inc. | -11.89 Million USD | 98.945% |
| Stratec SE | 14.42 Million USD | 100.87% |
| Vycor Medical, Inc. | -69.69 Thousand USD | -80.118% |
| Heart Tronics, Inc. | -13.32 Million USD | 99.058% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 99.106% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 99.514% |
| VMS Rehab Systems, Inc. | 46.44 USD | 270397.158% |
| Guided Therapeutics, Inc. | -3.48 Million USD | 96.402% |
| Ingen Technologies, Inc. | -5.06 Million USD | 97.52% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | 86.142% |
| United American Healthcare Corporation | 723 Thousand USD | 117.362% |
| ECGI Holdings, Inc. | -3.61 Million USD | 96.524% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | 80.924% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | 82.489% |
| Urologix, Inc. | -7.6 Million USD | 98.35% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | 92.589% |
| Nexeon MedSystems Inc. | -2.17 Million USD | 94.236% |
| SS Innovations International, Inc. | -20.94 Million USD | 99.401% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | 84.407% |
| Smith & Nephew plc | 263 Million USD | 100.048% |
| NIOX Group Plc | 13.64 Million USD | 100.92% |
| Fuse Medical, Inc. | 1.45 Million USD | 108.598% |
| Broncus Holding Corporation | -28.09 Million USD | 99.553% |
| Brain Scientific Inc. | -12.34 Million USD | 98.983% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 99.572% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | 21.668% |